Early virologic response to treatment with peginterferon alfa‐2b plus ribavirin in patients with chronic hepatitis C

By G. Davis, John B. Wong, J. Mchutchison, M. Manns, J. Harvey, J. Albrecht. Hepatology, 2003

886 citations recorded by the source corpus.

Subfields: Epidemiology, Hepatology

View Paper: https://www.semanticscholar.org/paper/ef0b1cc8a3150f9624bc817ac5e80a4b7c8204ff

Citations in the corpus

• EASL Clinical Practice Guidelines: management of hepatitis C virus infection. (2011, background): “In patients with detectable HCV RNA (P50 IU/ml) at week 24, treatment should also be stopped due to a minimal chance of SVR (1–3%) [55,78,91,92].”